EUROPID Presentation
|
|
- Shon McCormick
- 5 years ago
- Views:
Transcription
1 EUROPID Presentation A presentation to give an overall view of PIDs in Europe. This has been presented at the EU Parliament and can be translated for use in support of national requests for funding PID services.
2 Immune system The major role of the IMMUNE SYSTEM is the defense of the host. The most important function is the fight against infections. QLRT FP5 2
3 Immune Deficiences Immunodeficiences - defects in the function of immune system Primary - PID genetic disorders, mutation in genes coding for immune system components; they can be, and often are, inherited Secondary - deficiences caused by other conditions, for example AIDS or excessive malnutrition QLRT FP5 3
4 How do Primary Immunodeficiencies happen? PID are mostly genetic - so they are present in families Patients do not catch them - Infants are born with the disease, though it may not be apparent until adulthood, as found in diabetes So babies, children & adults can be affected QLRT FP5 4
5 The immune system is complex Immune system uses mechanisms that developed over billions of years The result is that there are very many genes that can go wrong i.e. mutate If a pathway no longer functions after a mutation that involves immunity, a PRIMARY IMMUNE DEFICIENCY results QLRT FP5 5
6 The result for the patient is Severe and recurrent infections with common bugs a LIFE TIME of frequent infections, hospitalisation and in some cases, intensive care The result for healthcare system is Costly use of healthcare resources because QLRT FP5 6
7 The patients suffer. RECURRENT infections lifelong SEVERE infections bad enough to be in hospital/ intensive care or leading to lifelong disability or, rarely, to die even if treated PERSISTENT infections - many months off work or school, due to infections that antibiotics do not cure, despite several & types of antibiotics QLRT FP5 7
8 PIDs are common, but easily missed The correct diagnosis of PID is easily missed if it is not thought about Often each infection is treated, but no-one thinks about an underlying cause Tests to make the diagnosis are cheap & widely available - [3-9 euros for a test]: it s awareness of PIDs which is missing QLRT FP5 8
9 A European register of PIDs This was put together by ESID over 10 years ago 26 countries entered a total of >10,000 patients in this period Now an online register has started to capture more patients in more countries in Europe QLRT FP5 9
10 Prevalence of PIDs in Europe Yugoslavia Germany France Poland Hungary Portugal Czech UK Spain Sweden This graph shows the number of PID patients in the ESID register per million in each country. It is an indication of how aware different countries are of these conditions. QLRT FP5 10
11 As is shown in last graph.. Number of PID patients per million population is variable: 5 per million in Germany to 47 per million in Sweden An appropriate mean for PID patients needing immediate treatment seems to be 25 per million There are at least twice as many patients with milder types of PID for whom medical attention and treatment are also needed. QLRT FP5 11
12 What does this mean? Sweden has highest prevalence; are they using different diagnostic criteria? ESID is working on standardised criteria Is the rest of Europe is too low and are there patients with PID who haven t been diagnosed? Yes - We need improved awareness of PIDs (medical and lay) & access to specialist centres for PID patients QLRT FP5 12
13 Are all PIDs equally severe? NO - they differ widely in the severity of the disease. the severity reflects the extent of the immunodeficiency The most severe PID leads to the death before the age of 2 years - as both immune cells & antibodies are missing On the other side of the spectrum, partial antibody deficiency causes milder, but still repeated, infections QLRT FP5 13
14 Grades of SEVERITY of Primary Immune Deficiencies Cells and antibodies are defective Antibody failure Only some antibodies missing Severe Combined Immune Deficiency Antibody deficiency Partial antibody deficiency QLRT FP5 14
15 Treatment depends on what is missing; cells/antibodies/both Replacement of protective antibodies by immunoglobulin therapy (since 1952) Bone marrow transplantation to replacement of immune cells (since 1968) Gene therapy to replace genes of the immune system (since 1990, and successfully since 2001) QLRT FP5 15
16 Replacement of antibodies by Immunoglobulin therapy Two routes Intravenous Subcutaneous Patients can be trained to give their own infusions at home, under a Home Therapy programme QLRT FP5 16
17 Subcutaneous Ig therapy in child QLRT FP5 17
18 Intravenous therapy at home QLRT FP5 18
19 Bone marrow transplantation to replace immune cells Life saving for Severe Combined Immune Deficiency Need to recognise early QLRT FP5 19
20 Need for an early diagnosis & treatment of a severe PID A healthy baby until 4 months old, then Persistent cough Diarrhoea Growth failure Neurological regression Found to lack antibodies & T immune cells Could have been saved by bone marrow transplantation BUT IT WAS TOO LATE QLRT FP5 20
21 Benefits of early diagnosis and optimal treatment by bone marrow transplant Afterwards the genetic defect was found Parents informed that there was a 25% chance that this could occur again in any pregnancy Prenatal diagnosis was done when the mother was pregnant next time Another affected foetus BUT this time a chance to save the baby s life QLRT FP5 21
22 Benefits of optimal treatment Transplant done in utero, using dad s bone marrow stem cells A healthy 2.8 Kg baby was delivered at 38 weeks of gestation - he has dad s immune system. Home at 2 weeks - normal immune function Now 6 six years old, healthy & lives at home. In first grade at elementary school;well. No need for drugs - an active child. QLRT FP5 22
23 Primary Immune Deficiency Diseases where we are now Current estimates indicate that as many as 70-90% of PI s are still undiagnosed undiagnosed patients These patients experience unnecessary suffering and depend heavily on healthcare resources for the treatment of lifelong complications and disabilities that result from untreated PIDs QLRT FP5 23
24 The EU s Public Health Programme why PI s are relevant The EU s Public Health Programme priorities include: improving information & knowledge for the development of public health strategies promoting health, & so preventing disease Immune deficiency diseases are a clear area where lack of information/knowledge among doctors, sufferers and parents of sufferers is a barrier to the promotion of health and disease prevention. QLRT FP5 24
25 The EU s contribution to PID s so far.. EU research grants in 4th and 5th Research Frameworks Enabled setting up the ESID register for PIDs Linked expert centers in Europe for sharing data, describing new diseases & coordinating treatments Improved understanding of mechanisms of disease - led to first clinical success of gene therapy in SCID in several countries & sharing of protocols and experience in Italy, France, UK QLRT FP5 25
26 How will a Public Health approach benefit patients in the EU? o Create the link between existing research programmes o Reach out to patients & doctors Promote awareness as Early diagnosis is essential to cure and prevent long term complications and disability QLRT FP5 26
27 How will a Public Health approach benefit patients in the EU? Provide equal opportunities Set up systems that reduce unequal access to diagnosis & treatment in Europe Monitor efficacy and safety of interventions Build on and extend registries already in place Ensure information used can be utilised effectively by physicians QLRT FP5 27
28 European Parliament Directive 2004 PIDs - priority for Action in Rare Diseases, within the 2005 Work Plan of the Public Health Programme PIDs - included as part of the Life Sciences Programme within 7 th Research Framework Programme Ministries of Health in all Member States support the development of expertise to increase accurate diagnosis & eliminate senseless suffering QLRT FP5 28
29 Educational Opportunities ESID spring and summer schools For teaching and training young clinicians and scientists Primary goal of education on all aspects of primary immunodeficiencies Educational symposia ESID meetings with International Patient Organisation of Primary Immunodeficiencies (IPOPI) & International Nursing Group for Immunodeficiencies (INGID) Educational exchanges across Europe QLRT FP5 29
D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells
Disclaimer: The content of this Deliverable represents the views of the author only and is his/her sole responsibility; it cannot be considered to reflect the views of the European Commission and/or the
More informationD7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells
Disclaimer: The content of this Deliverable represents the views of the author only and is his/her sole responsibility; it cannot be considered to reflect the views of the European Commission and/or the
More informationTwenty-five-years history of the Department of Immunology at the Children s Memorial Health Institute in Warsaw
Immunological forum Twenty-five-years history of the Department of Immunology at the Children s Memorial Health Institute in Warsaw EWA BERNATOWSKA This year the Department of Immunology at the Children
More informationTransparency, Equity, Ethics: access to care. quality of life. Improving. and patients. An Agency of the French Ministry of Health
An Agency of the French Ministry of Health Transparency, Equity, Ethics: Improving access to care and patients quality of life AgenceBiomedecine_Plaquette_GB.indd 1 25/08/14 12:15 Contents P.1 Agence de
More informationState of provision of Hearing Aids in Europe
Creating a barrier-free Europe for all hard of hearing citizens State of provision of Hearing Aids in Europe 2018 Report 1 Executive Summary Dear Reader, We are pleased to share the report examining affordability
More informationimmunodeficiency (ADA-SCID)
ADA-SCID Adenosine deaminasedeficient severe combined immunodeficiency (ADA-SCID) Additional information for families hello@piduk.org 0800 987 898 www.piduk.org About this leaflet This leaflet has been
More informationNEMO deficiency syndrome
NEMO NEMO deficiency syndrome hello@piduk.org 0800 987 8986 www.piduk.org About this leaflet This leaflet has been produced jointly between PID UK, Great Ormond Street Hospital (GOSH) and the Great North
More informationDisorder name: Severe Combined Immunodeficiency Acronym: SCID
Genetic Fact Sheets for Parents Other Disorders Screening, Technology, and Research in Genetics is a multi-state project to improve information about the financial, ethical, legal, and social issues surrounding
More informationIgG subclass deficiencies
IgG subclass deficiencies hello@piduk.org 0800 987 8986 www.piduk.org About this booklet This booklet provides information on IgG subclass deficiencies. It has been produced by the PID UK Medical Advisory
More informationIPOPI First Vietnamese PID Patients-Doctors National Meeting Held at the Baoson Hotel, Hanoi, Vietnam hrs 3 rd December 2015
IPOPI First Vietnamese PID Patients-Doctors National Meeting Held at the Baoson Hotel, Hanoi, Vietnam 9.00-15.00hrs 3 rd December 2015 Report 1. Introduction The first IPOPI Vietnamese PID Patients-Doctors
More informationPalliative nursing care of children and young people across Europe
Palliative nursing care of children and young people across Europe Results of a postal survey in August 2016 Updated in April 2017 (presented at the 29th PNAE-meeting in Naples/Italy on 28th April 2017)
More informationHAEMATOPOIETIC STEM CELL TRANSPLANTATION
PRIMARY IMMUNODEFICIENCIES HAEMATOPOIETIC STEM CELL TRANSPLANTATION HAEMATOPOIETIC STEM CELL TRANSPLANTATION 1 PRIMARY IMMUNODEFICIENCIES KEY ABBREVIATIONS CID GvHD HSCT IPOPI PID SCID BMT HSC Combined
More informationNATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SCOPE. Nutrition support in adults: oral supplements, enteral and parenteral feeding.
NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE 1 Guideline title SCOPE Nutrition support in adults: oral supplements, enteral and parenteral feeding. 1.1 Short title Nutrition support 2 Background a) The National
More informationX-linked agammaglobulinemia (XLA)
X-linked agammaglobulinemia (XLA) hello@piduk.org 0800 987 898 www.piduk.org About this booklet This booklet provides information on X-linked agammaglobulinemia (XLA). It has been produced by the PID UK
More informationHaemophagocytic lymphohistiocytosis (HLH)
HLH Haemophagocytic lymphohistiocytosis (HLH) Information for families hello@piduk.org 0800 987 8986 www.piduk.org About this leaflet This booklet has been produced jointly between PID UK, Great Ormond
More informationTHE CVD CHALLENGE IN NORTHERN IRELAND. Together we can save lives and reduce NHS pressures
THE CVD CHALLENGE IN NORTHERN IRELAND Together we can save lives and reduce NHS pressures The challenge of CVD continues today. Around 225,000 people in Northern Ireland live with the burden of cardiovascular
More informationHepatitis B vaccine alone or with HBIG in neonates of HBsAg+/HBeAg- mothers: a systematic review and meta-analysis.
Hepatitis B vaccine alone or with HBIG in neonates of HBsAg+/HBeAg- mothers: a systematic review and meta-analysis. Vana Papaevangelou (Greece) National and Kapodistrian University of Athens Chang SemFNM
More informationCost of Disorders of the Brain in Europe Gustavsson et al. Cost of disorders of the brain in Europe Eur. Neuropsych. (2011) 21,
Cost of Disorders of the Brain in Europe 2010 Gustavsson et al. Cost of disorders of the brain in Europe 2010. Eur. Neuropsych. (2011) 21, 718-779 Steering Committee Prof Jes Olesen 1 Prof Bengt Jönsson
More informationBACKGROUND AND RATIONALE
ULTRA RARE DISEASE EXAMPLE: SURVIVAL IN PATIENTS WITH NIEMANN PICK-C DISEASE Daniel Rosenberg, PhD Head of Epidemiology BACKGROUND AND RATIONALE Niemann Pick Type-C (NP-C) disease is an ultra rare condition
More informationPrimary Immune Deficiency: A guide for Teachers.
Primary Immune Deficiency: A guide for Teachers. Produced by KIDS Foundation a division of IDFNZ 2009 IDFNZ KIDS Foundation would like to acknowledge the support of Pub Charity in the printing of this
More informationUnderage drinking in Europe
Underage drinking in Europe There are two major studies on underage drinking which are published every 4 years: HBSC (Health Behaviour in School-aged Children) and ESPAD (The European School survey Project
More informationSHOULD VACCINES BE COMPULSORY?
The Big Debate SHOULD VACCINES BE COMPULSORY? Friday 02 March 2018 SHOULD VACCINES BE COMPULSORY? THE DILEMMA A change in French law means that all parents must now vaccinate children born on 1 January
More informationType 1 Diabetes Australian Research Impact Analysis
Type 1 Diabetes Australian Research Impact Analysis Executive Overview Summary Type 1 diabetes research in Australia Australia is making a significant contribution to the quantity and quality of the global
More informationPlacing Donation within End-of-Life Care in Intensive Care in Europe
Placing Donation within End-of-Life Care in Intensive Care in Europe Prof Chris Rudge CBE FRCS Madrid June 28 th 2013 Agenda 1. Introduction 1. The wide variation in Organ Donation across Europe 2. What
More informationEuropean actions in the field of transplantation & blood transfusion
European actions in the field of transplantation & blood transfusion Andrzej Rys Director Directorate Health Systems and Products Madrid, 27 June 2013 1 Blood Tissues and cells Organs 2 Blood transfusion
More informationDiabetes. The Policy Puzzle: Towards Benchmarking in the EU 25. International Diabetes Federation European Region
Diabetes The Policy Puzzle: Towards Benchmarking in the EU 25 Federation of European Nurses in Diabetes International Diabetes Federation European Region T A B L E O F C O N T E N T S Foreword 3 Executive
More informationAudit support for continuous subcutaneous insulin infusion for the treatment of diabetes mellitus (review of technology appraisal guidance 57)
Audit support for continuous subcutaneous insulin (review of technology appraisal guidance 57) Issue date: 2008 Audit support Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus
More informationCOMMISSION OF THE EUROPEAN COMMUNITIES
COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 22.12.2008 COM(2008) 882 final REPORT FROM THE COMMISSION TO THE COUNCIL, THE EUROPEAN PARLIAMENT, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE
More informationBiology Report. Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?
Biology Report Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis? Introduction Tuberculosis is a serious disease caused by the bacterium Mycobacterium
More informationPrimary Palliative Care Task Force. Update 3,Montreal, Oct Taskforce Members. Scott Murray, Scotland Eric van Rijswijk, Holland
Primary Palliative Care Task Force Update 3,Montreal, Oct 2013 Taskforce Members Scott Murray, Scotland Eric van Rijswijk, Holland Nils Schneider, Bart Van den Eynden, Xavier Gomez, Trine Brogaard, Tiago
More informationStay healthy! A guide for patients and their families. Primary immunodeficiencies. Stay healthy! A guide for patients and their families
Stay healthy! A guide for patients and their families Stay healthy! A guide for patients and their families Stay healthy! A guide for patients and their families (1 st edition), January 2012 International
More informationClinical Evidence in the Daily Work of an Anthroposophic Hospital Dr. med. Harald Matthes, Medical Director, Havelhöhe Hospital in Berlin
Programme Venue: Time: Chair: Presentations: Members Salon, European Parliament 8:00 9:30 am Marian Harkin MEP Research Evidence in Homeopathy: Overview of published clinical investigations Robert Mathie
More informationBone marrow transplantation for PID
BMT Bone marrow transplantation for PID hello@piduk.org 0800 987 898 www.piduk.org About this leaflet Bone marrow transplant (BMT; also known as haematopoietic stem cell transplant or HSCT) is increasingly
More informationNational Clinical Programme for Rare Diseases Prof. Eileen Treacy April 7 th,
National Clinical Programme for Rare Diseases Prof. Eileen Treacy April 7 th, 2017 1 European Reference Networks http://ec.europa.eu/health/ern/toolkit_en A European Framework for Rare Disease Services:
More informationPerspectives from regions: successes and challenges in promoting seasonal influenza vaccine usage in the EU
Perspectives from regions: successes and challenges in promoting seasonal influenza vaccine usage in the EU N. Safrany European Commission Pr. A. Nicoll ECDC 2 nd WHO GAP mtg 12-14 July 2011 Background
More informationCHLAMYDIA, GONORRHEA & SYPHILIS: STDS ON THE RISE
CHLAMYDIA, GONORRHEA & SYPHILIS: STDS ON THE RISE What are sexually transmitted diseases (STDs)? Sexually transmitted diseases (STDs) are passed from person to person through sexual activity. These infections
More informationCHLAMYDIA, GONORRHEA & SYPHILIS: STDS ON THE RISE
CHLAMYDIA, GONORRHEA & SYPHILIS: STDS ON THE RISE What are sexually transmitted diseases (STDs)? Sexually transmitted diseases (STDs) are passed from person to person through sexual activity. These infections
More informationFREQUENTLY ASKED QUESTIONS BONE MARROW / STEM CELL DONATION
FREQUENTLY ASKED QUESTIONS BONE MARROW / STEM CELL DONATION About Anthony Nolan Anthony Nolan is a pioneering charity that saves the lives of people with blood cancer who need a bone marrow, or stem cell,
More informationSevere Combined Immune Deficiency (SCID) A Guide for Parents Following a Diagnosis
Severe Combined Immune Deficiency (SCID) A Guide for Parents Following a Diagnosis Copyright 2014 by Immune Deficiency Foundation This translation was created by an entity other than IDF. As such, while
More informationEPAG UPDATE. Lenja Wiehe. European Patient Advocacy Groups Manager, EURORDIS
EPAG UPDATE Lenja Wiehe European Patient Advocacy Groups Manager, EURORDIS Patient Centre & Empowerment European Reference Networks (ERNs) created on founding principles of patient-centred care, patient
More informationJoint Programming in Neurodegenerative Disease Research (JPND)
Joint Programming in Neurodegenerative Disease Research (JPND) Building Alliances and Collaborations Prof. Philippe Amouyel, MD, PhD JPND Chair France Disclosure CEO of Fondation Plan Alzheimer Conference
More informationIMMUNOGLOBULIN REPLACEMENT THERAPY: ONE SIZE DOESN T FIT ALL
PRIMARY IMMUNODEFICIENCIES IMMUNOGLOBULINS: ONE SIZE DOESN T FIT ALL IMMUNOGLOBULIN REPLACEMENT THERAPY: ONE SIZE DOESN T FIT ALL 1 PRIMARY IMMUNODEFICIENCIES ABBREVIATIONS IG IPOPI IV PID SC Immunoglobulins
More informationName of Primary Immune Deficiency: Patient/Applicant Name: Parent/Carer Name (if child under 16): Address: Phone: GP: Immunologist:
Name of Primary Immune Deficiency: Patient/Applicant Name: Parent/Carer Name (if child under 16): Address: Phone: GP: Immunologist: Date: To whom it may concern: A Primary Immune Deficiency (PI) is a genetic
More informationThe Spanish Society of Medical Oncology: objectives, structure and history
The Spanish Society of Medical Oncology: objectives, structure and history The Spanish Society of Medical Oncology (SEOM) brings together Spanish specialists who are dedicated solely to fighting cancer
More informationHuman Health Using nuclear techniques to improve health around the world
Human Health Using nuclear techniques to improve health around the world With its wide range of activities and expertise in nuclear science and medicine, the IAEA is helping Member States use nuclear techniques
More informationWhat Women Need to Know: The HIV Treatment Guidelines for Pregnant Women
: The HIV Treatment Guidelines for Pregnant Women : The HIV Treatment Guidelines for Pregnant Women What Women Need to Know: Prepared by Elaine Gross, RN, MS, CNS-C National Pediatric & Family HIV Resource
More informationProtecting the unborn baby from alcohol. Brief Summary
Protecting the unborn baby from alcohol 17 th September 2013 European Parliament, Brussels Brief Summary October 2013 Organised by: Hosted by: With the support of: 17 Rue Archimede I 1000 Brussels I Belgium
More informationChagas Initiative. Chagas disease is one of the main public health problems in Latin America, where it is more common than malaria
Chagas Initiative Chagas Initiative The Chagas Initiative aims to increase access to effective diagnosis and treatment for patients with Chagas disease, both in endemic and non-endemic countries, and to
More informationWhat are stem cells? A stem cell can differentiate into any one of 220 different specialised cells in the body STEM CELLS
What are stem cells? Stem cells are often called MASTER CELLS, and form the foundation for your entire body as building blocks for the blood, immune system, tissue and organs. They can REPLICATE or REGENERATE
More informationGrown-up congenital heart disease care throughout Europe
Grown-up congenital heart disease care throughout Europe P. Moons, F. Meijboom, H. Baumgartner, P.T. Trindade, E. Huyghe, H. Kaemmerer on behalf of the ESC Working Group on Grown-up Congenital Heart Disease
More informationDeceased donation data in the UK. Paul Murphy National Clinical Lead for Organ Donation United Kingdom
Deceased donation data in the UK Paul Murphy National Clinical Lead for Organ Donation United Kingdom Deceased donation data in the UK And the story behind it Paul Murphy National Clinical Lead for Organ
More informationAutoimmune lymphoproliferative syndrome (ALPS)
ALPS Autoimmune lymphoproliferative syndrome (ALPS) Information for families hello@piduk.org 0800 987 8986 www.piduk.org About this leaflet This leaflet is designed to help answer the questions families
More informationECDC and Spanish Ministry of Health workshop:
ECDC and Spanish Ministry of Health workshop: Improving the monitoring of HIV among migrant populations in Europe, Madrid, 3-4 October 2013 Teymur Noori EU Commission Thank Tank on HIV/AIDS Luxembourg,
More information5 Diagnosis. Timely diagnosis. Back to contents
5 5 Diagnosis Back to contents Study Advisory Group questions: Are there delays in diagnosis? Is there variation in how the cerebral palsies are described? signs can fluctuate, to avoid over-diagnosis
More informationOneMatch Stem Cell and Marrow Network. Training Guide
OneMatch Stem Cell and Marrow Network Training Guide What is OneMatch all about? OneMatch is a Canadian Program that matches and coordinates the collection of stem cells from potential donors to help save
More informationQuestion 1: Has your doctor or health care professional told you that you had type 1 or type 2 diabetes?
DIABETES - Questions list Question 1: Has your doctor or health care professional told you that you had type 1 or type 2 diabetes? Type 1 diabetes Type 2 diabetes Neither Routing rule: ( Type 1 Diabetes->2
More informationClinical Immunodeficiency. Dr Claire Bethune Consultant Immunologist
Clinical Immunodeficiency Dr Claire Bethune Consultant Immunologist Peninsula Specialist Immunodeficiency and Allergy service Eden Unit, Derriford https://www.plymouthhospitals.nhs. uk/eden Or Google Immunology
More informationReproductive Technology, Genetic Testing, and Gene Therapy
Michael Cummings Chapter 16 Reproductive Technology, Genetic Testing, and Gene Therapy David Reisman University of South Carolina 16.1 Infertility Is a Common Problem In the US, about 13% of all couples
More informationIs there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?
Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis? Introduction Tuberculosis is a serious disease caused by the bacterium Mycobacterium tuberculosis.
More informationState of the Art of Rare Disease Activities in EU Member States and Other European Countries. Slovak Republic Report
State of the Art of Rare Disease Activities in EU Member States and Other European Countries Slovak Republic Report Definition of a Rare Disease The Slovak Republic has adopted the European Commission
More informationCOLORECTAL CANCER: A CHALLENGE FOR HEALTHY LIFESTYLE, SCREENING AND PROPER CARE
COLORECTAL CANCER: A CHALLENGE FOR HEALTHY LIFESTYLE, SCREENING AND PROPER CARE Brno, 29 May 2015: For the fourth time in a row, the second largest city of the Czech Republic will host the European Colorectal
More informationThe health economic landscape of cancer in Europe
1 Approval number The health economic landscape of cancer in Europe Bengt Jönsson, Professor Emeritus of Health Economics Stockholm School of Economics 2 Disclaimer This presentation was developed by Professor
More informationHomeopathy and Anthroposophic Medicine THEIR PLACE IN EUROPEAN HEALTH CARE
Homeopathy and Anthroposophic Medicine THEIR PLACE IN EUROPEAN HEALTH CARE A thriving European tradition Homeopathy and anthroposophic medicine are part of a long-standing European therapeutic tradition
More informationBurden of Paediatric Rotavirus Gastroenteritis & Potential Impact of Rotavirus Vaccination
Carlo GIAQUINTO Pediatrics Department University of Padova, Italy Burden of Paediatric Rotavirus Gastroenteritis & Potential Impact of Rotavirus Vaccination Preliminary results 7th International Rotavirus
More informationHEALTHCARE DESERTS. Severe healthcare deprivation among children in developing countries
HEALTHCARE DESERTS Severe healthcare deprivation among children in developing countries Summary More than 40 million children are living in healthcare deserts, denied the most basic of healthcare services
More informationPatient information. Subcutaneous Immunoglobulin Therapy and Home Treatment ( SCIG) Infection and Immunity Directorate PIF 1443 V2
Patient information Subcutaneous Immunoglobulin Therapy and Home Treatment ( SCIG) Infection and Immunity Directorate PIF 1443 V2 An overview of subcutaneous infusion of Immunoglobulin Many patients with
More informationPROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS (PFIC)
The Childhood Liver Disease Research Network strives to provide information and support to individuals and families affected by liver disease through its many research programs. PROGRESSIVE FAMILIAL INTRAHEPATIC
More informationUnderstanding your child s heart. Patent ductus arteriosus
Understanding your child s heart Patent ductus arteriosus 15 About this book If you re reading this book, you ve probably just had some very upsetting news, and have lots of questions running through your
More informationCarrying Beta Thalassaemia A carrier can use this booklet to
Carrying Beta Thalassaemia A carrier can use this booklet to help explain carrying beta to their partner, blood relatives and others. show to any health professional (doctor, nurse or midwife) they see
More informationUnderstanding PIDD. Primary Immunodeficiency Disease (PIDD)
Understanding PIDD Primary Immunodeficiency Disease (PIDD) Understanding PIDD Primary Immunodeficiency Disease (PIDD) What is Primary Immunodeficiency? Primary Immunodeficiency (PIDD or PID) is a disease
More informationSubcutaneous immunoglobulin therapy: a new option for patients with primary immunodeficiency diseases. Mai Thị Bích Ngọc
Subcutaneous immunoglobulin therapy: a new option for patients with primary immunodeficiency diseases Mai Thị Bích Ngọc Background Primary immunodeficiency diseases (PIDD): group of over 150 disorders
More informationERN-BOND White Paper on Diagnosis of Osteogenesis Imperfecta: Synopsis
ERN-BOND White Paper on Diagnosis of Osteogenesis Imperfecta: Synopsis ERNs provide key EU-added value for patients living with rare diseases in the EU, breaking down geographical barriers to diagnosis,
More informationEuropean Community Pharmacy: a reference in Public Health
European Community Pharmacy: a reference in Public Health Ilaria Passarani PGEU Secretary General 4 October 2018, Burgos, Spain Pharmaceutical Group of European Union Members: Professional Bodies & Pharmacists
More informationThalassaemia. What is thalassaemia? What causes thalassaemia? What are the different types of thalassaemia?
Thalassaemia Thalassaemia is an inherited condition affecting the blood. There are different types, which vary from a mild condition with no symptoms, to a serious or lifethreatening condition. For the
More informationScreening for hepatitis B, HIV and syphilis. An easy guide to screening tests when you are pregnant
Screening for hepatitis B, HIV and syphilis An easy guide to screening tests when you are pregnant Contents: what is in this booklet Page Your choice 3 About the test 4 Hepatitis B 5 HIV 7 Syphilis 8 Test
More informationHAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS HLH ADULTS & Young People
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS HLH ADULTS & Young People Histiocytosis UK Introduction Despite the misery it causes, Histiocytosis is too rare a disease to have generated substantial research in medical
More informationOverview of drug-induced deaths in Europe - What does the data tell us?
Overview of drug-induced deaths in Europe - What does the data tell us? João Matias, Isabelle Giraudon, Julián Vicente EMCDDA expert group on the key-indicator Drug-related deaths and mortality among drug
More informationBronchiectasis. What is bronchiectasis? What causes bronchiectasis?
This factsheet explains what bronchiectasis is, what causes it, and how it is diagnosed and managed. More detailed information is available on the Bronchiectasis Patient Priorities website: www.europeanlunginfo.org/bronchiectasis
More informationCHRONIC CONDITIONS FYI
CHRONIC CONDITIONS FYI AIDS More than 2,500 cases of HIV/AIDS have been identified in Nebraska. Nationwide, this number is more than 1.2 million. ALS (Amyotrophic Lateral Sclerosis) There are 87 people
More informationSaving children and mothers
Saving children and mothers child survival & development programme UNICEF South Africa/Blow Fish UNICEF South Africa/Schermbrucker South Africa s progress in healthcare The Statistics Under-five 62/1,000
More informationPrivigen solution for infusion
Privigen solution for infusion Haematology Patient Information What is is Privigen? Privigen? Privigen belongs in a class of medicines called human normal immunoglobins. Immunoglobulins are also called
More informationFamilial Hypercholesterolaemia
Familial Hypercholesterolaemia What is the disease? FH is due to mutations of our DNA which prevent our bodies breaking down cholesterol Patients will have very high cholesterol from birth Very high cholesterol
More informationSTRATEGIC APPROACH & WORKPLAN 2007
Rare Diseases Europe STRATEGIC APPROACH 2007-2009 & WORKPLAN 2007 Paris, March 2007 www.eurordis.org Contents Our strategic approach 2007 2009 o Eurordis in 2010 o Strategic orientations o Priorities 2007-2009
More informationHealth related issues in Moldova. Stanislav Groppa, MD, PhD, Prof., Acad. Victor Vovc, MD, PhD, Prof.
Health related issues in Moldova Stanislav Groppa, MD, PhD, Prof., Acad. Victor Vovc, MD, PhD, Prof. Health Research institutions network of the Republic of Moldova SUMPh Nicolae Testemitanu Mother and
More informationAt-A-Glance report 2013
At-A-Glance report 213 Cystic Fibrosis in Europe Facts and Figures 213 The European Cystic Fibrosis Society Patient Registry (ECFSPR) is happy to present this report with key information about how cystic
More informationProgramme of community action in the field of health ( ) 2012 ACTIVITY REPORT DELIVERABLE 8: EVALUATION REPORT
Page 1 Programme of community action in the field of health (2008-2013) 2012 ACTIVITY REPORT DELIVERABLE 8: EVALUATION REPORT Page 2 Description of the deliverable An end of year external evaluation report
More informationPrimary immunodeficiencies. Primary immunodeficiencies in adults
Primary in adults Primary immunodeficiencies Primary immunodeficiencies in adults Primary immunodeficiencies Primary immunodeficiencies Primary immunodeficiencies in adults (1 st edition). December 2012
More informationThe European Brain Council
The European Brain Council Dr C. Ian Ragan, Executive Director Dr Mary G. Baker MBE, Vice President Committee on Industry, Research and Energy Public Hearing on Mental Health Research: Scientific Progress
More informationLa Réanimation en Europe
La Réanimation en Europe - la même chose partout?- Jean-Daniel Chiche, MD PhD MICU & Dept of Host-Pathogen Interaction Hôpial Cochin & Institut Cochin, Paris-F How could this be? How could this be? Always
More informationElements for a Public Summary
VI.2 VI.2.1 Elements for a Public Summary Overview of disease epidemiology Nanogam is intended to be used for the treatment of diseases in patients who are suffering from a shortage of immunoglobulins
More informationWHO/HIV_AIDS/BN/ Original: English Distr.: General
WHO/HIV_AIDS/BN/2001.1 Original: English Distr.: General It is estimated that 4.3 million children have died of AIDS before their fifteenth birthday, nearly half a million in 2000. Another 1.4 million
More informationDraft ahus Patients Research Agenda
Important notice this is just a draft. 1. Disease onset Draft ahus Patients Research Agenda ahus Registry ahus Global Poll Rare Disease Day Video How transient is ahus due to pregnancy and is there a role
More informationDiabetes for CNAs. This course has been awarded two (2.0) contact hours. This course expires on August 31, 2017.
Diabetes for CNAs This course has been awarded two (2.0) contact hours. This course expires on August 31, 2017. Copyright 2005 by RN.com. All Rights Reserved. Reproduction and distribution of these materials
More informationGATA6 Syndrome. rarechromo.org
GATA6 Syndrome rarechromo.org What is GATA6 syndrome? GATA6 syndrome occurs when one of a person s two copies of the GATA6 gene doesn t work as it should. Our DNA is formed by 3 billion letters that contain
More informationSpecific Requirements
Specific Requirements AIMS Specific requirements your patients have for transfusion and how this is managed Classify which patients require: Irradiated components CMV negative components Washed components
More informationProject Meeting Prague
Project Meeting Prague IO1 Assessment 9.11.217 CHRISTINA PADBERG ON BEHALF OF FRANKFURT UAS Current Status Assessment matrix was fully evaluated Experts have been interviewed, Interviews were fully evaluated
More informationCounty of Santa Cruz. General Questions About Measles HEALTH SERVICES AGENCY. Public Health Division. What is measles?
County of Santa Cruz Public Health Division HEALTH SERVICES AGENCY POST OFFICE BOX 962, 1080 EMELINE AVE., SANTA CRUZ, CA 95060 TELEPHONE: (831) 454-4000 FAX: (831) 454-4770 General Questions About Measles
More informationUseful EU information on organ donation and transplantation
Useful EU information on organ donation and transplantation 1) EU funded and co-funded Projects European Training Program on Organ Donation - EPTOD The aim of this project is to design a professional European
More information